SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...

Treatment with ambroxol for symptoms of Parkinson’s disease dementia was safe, but its efficacy was undetermined in a small ...

The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks ...

Prajwal's Early Struggles with Gaucher Disease Prajwal, who is now 17 years old and from Bangalore, was diagnosed with Gaucher disease several months after birth.

Researchers believe the HPgV virus could be an environmental trigger or contributor to Parkinson's disease.

Gaucher disease, a rare disorder, is caused by inherited deficiency of the enzyme glucocerebrosidase. It is unique among the ultra-orphan disorders in that four treatments are currently approved by ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It is approved for treating respiratory conditions in Europe, but not for any ...

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future ...